Provided By GlobeNewswire
Last update: Aug 14, 2024
WASHINGTON, Aug. 14, 2024 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the “Company”), a pharmaceutical company focused on developing new medicines for infectious diseases, reported today their financial results for the second quarter of 2024, ended June 30, 2024.
Read more at globenewswire.comNASDAQ:SXTPW (10/6/2025, 9:04:39 PM)
0.0468
+0.01 (+18.18%)
1.48
+0.06 (+4.23%)
Find more stocks in the Stock Screener